Ĭheung KS, Leung WK. Risk of gastric cancer development after eradication of Helicobacter pylori.

Estimation of Cancer Burden Attributable to Infection in Asia. Huang H, Hu XF, Zhao FH, Garland SM, Bhatla N, Qiao YL. Helicobacter pylori eradication for preventing gastric cancer. Roberts SE, Morrison-Rees S, Samuel DG, Thorne K, Akbari A, Williams JG. Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe. Įpplein M, Zheng W, Xiang YB, Peek RM, Li H, Correa P, Gao J, Michel A, Pawlita M, Cai Q. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Inverse association of Helicobacter pylori cagPAI genotypes with risk of cardia and non-cardia gastric adenocarcinoma. īakhti SZ, Latifi-Navid S, Zahri S, Yazdanbod A. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas. Shakeri R, Malekzadeh R, Nasrollahzadeh D, Pawlita M, Murphy G, Islami F, Sotoudeh M, Michel A, Etemadi A, Waterboer T, Poustchi H, Brennan P, Boffetta P, Dawsey SM, Kamangar F, Abnet CC. Hu J, La Vecchia C, Negri E, de Groh M, Morrison H, Mery L. Macronutrient intake and stomach cancer. Wang ZW, Li Y, Huang LY, Guan QK, Xu DW, Zhou WK, Zhang XZ. Helicobacter pylori infection contributes to high risk of ischemic stroke: evidence from a meta-analysis. Tseng CH, Tseng FH. Diabetes and gastric cancer: The potential links. p27(kip1) upregulated by hnRNPC1/2 antagonizes CagA (a virulence factor of Helicobacter pylori)-mediated pathogenesis.

Jin S, Wu M, Cao H, Ying S, Hua J, Chen Y. Influence of microbiota on immunity and immunotherapy for gastric and esophageal cancers. Ĭhen J, Hu S, Liang S, Chen Q, Yang Q, Zheng W, Ma W. Associations between the four toll-like receptor polymorphisms and the risk of gastric cancer: a meta-analysis. Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction. īornschein J, Wernisch L, Secrier M, Miremadi A, Perner J, MacRae S, O'Donovan M, Newton R, Menon S, Bower L, Eldridge MD, Devonshire G, Cheah C, Turkington R, Hardwick RH, Selgrad M, Venerito M, Malfertheiner P, Fitzgerald RC OCCAMS Consortium. Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of helicobacter pylori infection worldwide: A systematic review of studies with national coverage. Lee E, Liu L, Zhang J, Stern MC, Barzi A, Hwang A, Kim AE, Hamilton AS, Wu AH, Deapen D. Stomach Cancer Disparity among Korean Americans by Tumor Characteristics: Comparison with Non-Hispanic Whites, Japanese Americans, South Koreans, and Japanese. Epidemiology of gastric cancer and risk factors. Ĭavatorta O, Scida S, Miraglia C, Barchi A, Nouvenne A, Leandro G, Meschi T, De' Angelis GL, Di Mario F. Alterations of Gastric Microbiota in Gastric Cancer and Precancerous Stages. Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. īornschein J, Rokkas T, Selgrad M, Malfertheiner P. Gastric cancer: clinical aspects, epidemiology and molecular background. Nutrition and upper gastrointestinal cancers: An overview of current understandings. Gastric Cancer. 2014 Epub ahead of print. Kim HJ, Kim N, Kim HY, Lee HS, Yoon H, Shin CM, Park YS, Park DJ, Kim HH, Lee KH. Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Song M, Camargo MC, Weinstein SJ, Murphy G, Freedman ND, Koshiol J, Stolzenberg-Solomon RZ, Abnet CC, Männistö S, Albanes D, Rabkin CS.

Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis.

Pasquale j scida